Zobrazeno 1 - 10
of 141
pro vyhledávání: '"BAOGANG PENG"'
Autor:
Baifeng Qian, Haozhong Lin, Tian Lan, Muqi Li, Xiwen Wu, Shuirong Lin, Zimin Song, Shunli Shen, Baogang Peng
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Hepatocellular carcinoma (HCC) as a common tumor has a poor prognosis. Recently, a combination of atezolizumab and bevacizumab has been recommended as the preferred regimen for advanced HCC. However, the overall response rate of t
Externí odkaz:
https://doaj.org/article/6b115769beae4c28a9efa50cde7e0d9a
Autor:
Kaijun Huang, Wenxuan Xie, Shutong Wang, Qiao Li, Xiangling Wei, Bin Chen, Yunpeng Hua, Shaoqiang Li, Baogang Peng, Shunli Shen
Publikováno v:
Journal of Investigative Surgery, Vol 34, Iss 9, Pp 1011-1020 (2021)
Background Serine protease inhibitor Kazal type I (SPINK1) is highly expressed and promotes tumor progress in different cancers. This study aimed to evaluate SPINK1’s prognostic value and its role in hepatocellular carcinoma (HCC) progress. Methods
Externí odkaz:
https://doaj.org/article/2c777c3fc5db49c4bf1bfa19295d4f8e
Autor:
Lixin Ke, Jianming Shen, Jikun Feng, Jialin Chen, Shunli Shen, Shaoqiang Li, Ming Kuang, Lijian Liang, Cuncun Lu, Dongming Li, Qiang He, Baogang Peng, Yunpeng Hua
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2022)
The features and significance of somatic mutation profiles in hepatocellular carcinoma (HCC) have not been completely elucidated to date. In this study, 39 tumor specimens from HCC patients were collected for gene variation analysis by next-generatio
Externí odkaz:
https://doaj.org/article/c6d52d9f67834ddc85b44a270cb74240
Autor:
Fei Liu, Dan Liu, Kun Wang, Xiaohua Xie, Liya Su, Ming Kuang, Guangliang Huang, Baogang Peng, Yuqi Wang, Manxia Lin, Jie Tian, Xiaoyan Xie
Publikováno v:
Liver Cancer, Pp 1-17 (2020)
Background: We aimed to evaluate the performance of a deep learning (DL)-based Radiomics strategy designed for analyzing contrast-enhanced ultrasound (CEUS) to not only predict the progression-free survival (PFS) of radiofrequency ablation (RFA) and
Externí odkaz:
https://doaj.org/article/6c95af51c58d47ef937f6d94f8f7ae76
Autor:
Qiao Li, Lingyu Han, Shengnan Ruan, Shunli Shen, Qinghua Cao, Xiuqin Cai, Yuan Yan, Baogang Peng, Yunpeng Hua
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Neuromedin U (NMU) is a neuropeptide belonging to the neuromedin family. Recently, significant associations between NMU and several cancers have been reported. However, no studies have examined the association between NMU and hepa
Externí odkaz:
https://doaj.org/article/232c41dd7095420bbae2f1779c80ba44
Autor:
Hong Peng, Yi Zhang, Zhiwei Zhou, Yu Guo, Xiaohui Huang, Kenneth D. Westover, Zhaohui Zhang, Bin Chen, Yunpeng Hua, Shaoqiang Li, Ruiyun Xu, Nan Lin, Baogang Peng, Shunli Shen
Publikováno v:
EBioMedicine, Vol 46, Iss , Pp 105-118 (2019)
Background: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoin
Externí odkaz:
https://doaj.org/article/fcc8143fd2f24e23844ab141a7a27d45
Autor:
Qiao Li, Lei Ma, Shunli Shen, Yu Guo, Qinghua Cao, Xiuqin Cai, Juan Feng, Yuan Yan, Tianyu Hu, Shiya Luo, Lin Zhou, Baogang Peng, Zhonghan Yang, Yunpeng Hua
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-13 (2019)
Abstract Background Gut microbiota and the tumor microenvironment are thought to be critical factors that modulate the processes of liver diseases, including hepatocellular carcinoma (HCC). Interleukin-25 (IL-25) promotes type 2 immunity via alternat
Externí odkaz:
https://doaj.org/article/40f5d8d222154f63b3b0f92573732d77
Autor:
Shuling Chen, Huilin Jin, Zihao Dai, Mengchao Wei, Han Xiao, Tianhong Su, Bin Li, Xin Liu, Yu Wang, Jiaping Li, Shunli Shen, Qi Zhou, Baogang Peng, Zhenwei Peng, Sui Peng
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1530-1539 (2019)
Abstract Background The role of transarterial chemoembolization (TACE) as the standard treatment for intermediate‐stage hepatocellular carcinoma (HCC) is being challenged by increasing studies supporting liver resection (LR); but evidence of surviv
Externí odkaz:
https://doaj.org/article/954e9068d3ca48e0b436848747db6ba5
Autor:
Fuquan Liu, Zhenyuan Ning, Yanna Liu, Dengxiang Liu, Jie Tian, Hongwu Luo, Weimin An, Yifei Huang, Jialiang Zou, Chuan Liu, Changchun Liu, Lei Wang, Zaiyi Liu, Ruizhao Qi, Changzeng Zuo, Qingge Zhang, Jitao Wang, Dawei Zhao, Yongli Duan, Baogang Peng, Xingshun Qi, Yuening Zhang, Yongping Yang, Jinlin Hou, Jiahong Dong, Zhiwei Li, Huiguo Ding, Yu Zhang, Xiaolong Qi
Publikováno v:
EBioMedicine, Vol 36, Iss , Pp 151-158 (2018)
Clinically significant portal hypertension (CSPH) is associated with an incremental risk of esophageal varices and overt clinical decompensations. However, hepatic venous pressure gradient (HVPG) measurement, the gold standard for defining CSPH (HVPG
Externí odkaz:
https://doaj.org/article/8a61e9c0ae8c4cceb01c484ae581d116
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Background: Hepatocellular carcinoma (HCC) is one of the most common aggressive solid malignant tumors and current research regards HCC as a type of metabolic disease. This study aims to establish a metabolism-related mRNA signature model for risk as
Externí odkaz:
https://doaj.org/article/5cdfcb99991d4c95af5e4e71f9e878cf